NeoGenomics has appointed Warren Stone as its new Chief Executive Officer, effective as of early October. Alongside the leadership transition, the company issued a revenue forecast for the third quarter of 2026, estimating it to reach approximately $209 million. Following these announcements, the company's stock experienced a decline in market value.
